ArticleScientific reports2026

Efficacy and safety of RC48 alone or combined with PD-1 inhibitors in high-risk non-muscle invasive bladder cancer.

Xuanjun Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.